Literature DB >> 10229104

Vesicles bearing MHC class II molecules mediate transfer of antigen from antigen-presenting cells to CD4+ T cells.

P Y Arnold1, M D Mannie.   

Abstract

Previous studies have provided evidence that myelin basic protein (MBP)-specific rat T cells acquire antigen via transfer of preformed peptide/MHC class II complexes from splenic antigen-presenting cells (APC). The purpose of the present study was to determine how T cells acquire peptide/MHC class II complexes from APC in vitro. Our results show that a MHC class II+ T cell line, R1-trans, released MHC class II-bearing vesicles that directly stimulated MBP-specific CD4+ T cells. Vesicles expressing complexes of MHC class II and MBP were also specifically cytotoxic to MBP-specific T cells. Surviving T cells acquired MHC class II/antigen complexes from these vesicles by a mechanism that did not require protein synthesis but depended on specific TCR interactions with peptide/self MHC complexes. Furthermore, MBP/MHC class II-bearing vesicles enabled T cells to present MBP to other T cell responders. These studies provide evidence that APC release vesicles expressing preformed peptide/MHC class II complexes that interact with clonotypic TCR, allowing MHC class II acquisition by T cells. Vesicular transport of antigen/MHC class II complexes from professional APC to T cells may represent an important mechanism of communication among cells of the immune system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229104     DOI: 10.1002/(SICI)1521-4141(199904)29:04<1363::AID-IMMU1363>3.0.CO;2-0

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

Review 1.  T cell-mediated antigen presentation: a potential mechanism of infectious tolerance.

Authors:  M D Mannie
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Antigen-independent acquisition of MHC class II molecules by human T lymphocytes.

Authors:  Anita H Undale; Peter J van den Elsen; Esteban Celis
Journal:  Int Immunol       Date:  2004-09-06       Impact factor: 4.823

3.  Maternal Milk T Cells Drive Development of Transgenerational Th1 Immunity in Offspring Thymus.

Authors:  Mrinal K Ghosh; Virginia Nguyen; H Konrad Muller; Ameae M Walker
Journal:  J Immunol       Date:  2016-08-05       Impact factor: 5.422

Review 4.  Extracellular vesicle-mediated MHC cross-dressing in immune homeostasis, transplantation, infectious diseases, and cancer.

Authors:  Furong Zeng; Adrian E Morelli
Journal:  Semin Immunopathol       Date:  2018-03-28       Impact factor: 9.623

Review 5.  Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.

Authors:  Susmita Sil; Raghubendra Singh Dagur; Ke Liao; Eric S Peeples; Guoku Hu; Palsamy Periyasamy; Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-27       Impact factor: 4.147

6.  Rat bone marrow-derived dendritic cells, but not ex vivo dendritic cells, secrete nitric oxide and can inhibit T-cell proliferation.

Authors:  Timothy J Powell; Chris D Jenkins; Ryuichi Hattori; G Gordon MacPherson
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

Review 7.  Exosomes and nanotubes: Control of immune cell communication.

Authors:  Kessler McCoy-Simandle; Samer J Hanna; Dianne Cox
Journal:  Int J Biochem Cell Biol       Date:  2015-12-15       Impact factor: 5.085

Review 8.  Receptor-mediated T cell absorption of antigen presenting cell-derived molecules.

Authors:  Inkyu Hwang; DaLim Ki
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

9.  Preferential transfer of certain plasma membrane proteins onto T and B cells by trogocytosis.

Authors:  Sandrine Daubeuf; Anne Aucher; Christine Bordier; Audrey Salles; Laurent Serre; Gérald Gaibelet; Jean-Charles Faye; Gilles Favre; Etienne Joly; Denis Hudrisier
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

Review 10.  Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance.

Authors:  L A Smyth; B Afzali; J Tsang; G Lombardi; R I Lechler
Journal:  Am J Transplant       Date:  2007-06       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.